If ‘Love is the drug’ should Roxy Music be subject to regulatory scrutiny? Can The Verve say ‘The drugs don’t Work’ without conducting a clinical trial? We explore the harmonious worlds of pharma and music.
Dispatches from FT Global Pharmaceutical and Biotechnology conference, London
The global market for RFID products and services in the pharma industry will be worth $884m (€631m) in 2015, according to a report, but apprehensions about initial costs and return-on-investment need to be overcome.
Nigeria is collaborating with Interpol and setting up offices in India to curb the flow of counterfeits, in particular allegedly China produced fakes labelled “Made in India”, according to media reports.
Although India 'has carved out a significant portion of the world
pharma pie', an enormous change in mindset is needed if the country
is to become a global pharmaceutical hub, according to a new report
Indian chemical firm Syschem is planning to splash out up to $15m
(€11.4m) over two years to expand its manufacturing capacity – a
move the company said will facilitate its smooth entry into the
pharma industry and help cope with...
Despite the many challenges facing the pharma industry, drug
developers should be optimistic, and one of the reasons is the
increasing reliance on global outsourcing to speed development and
reduce costs, says new report.